GERM

ETFMG Treatments Testing and Advancements ETF
*Unless otherwise stated, data provided by FactSet.

GERM Fund Description

GERM tracks a tier-weighted, narrow index of US-listed global biotech companies that are engaged in the testing and treatments of infectious diseases.

GERM Factset Analytics Insight

GERM provides unique exposure to a subsector of biotech industry. The passively-managed fund holds companies that test and develop treatments against infectious diseases by focusing on companies at the forefront of R&D, vaccines, therapies and testing technologies. Companies included in the index must meet minimum market-cap and liquidity requirements. Also, companies must have an operating company structure; no pass-through securities. Selected stocks are weighted in tiers wherein the top five largest constituents receives 30% weight in the index in aggregate with an equal weight of 6% each, while the remaining securities are weighted by market-cap with 4% single security cap. Companies with market-cap of $15 billion or more are also equally weighted, receiving 10% portion of the portfolio in aggregate. The index is rebalanced and reconstituted every quarter.

GERM Charts And Performance

Price Chart ($)
Total Return Chart (%)
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
Compare
Reset
Select ETFs to compare their performance:
PERFORMANCE [as of 07/31/20] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
GERM 11.53% -- -- -- -- -- --
ticker (NAV) 11.35% -- -- -- -- -- --
Thomson Reuters Global Biotechnology & Medical Research -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

GERM Summary Data

ETFMG
06/17/20
Open-Ended Fund
0.68%
$74.01M
$5.41M
0.45%
N/A

GERM Portfolio Data

$19.98B
-36.15
5.79
--
N/A
56

GERM Index Data

Prime Treatments, Testing and Advancements Index
Tiered
Committee
Thomson Reuters Global Biotechnology & Medical Research

GERM Portfolio Management

0.68%
--
--
--

GERM Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

GERM Fund Structure

Open-Ended Fund
No
Yes
100% / 0%
N/A
N/A
Low
Daily
Cboe Book Viewer
Top Of Book
Last 10 Trades
Bats BZX Real-time Quote -

GERM Factset Analytics Block Liquidity

As of 08/03/20
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of GERM. GERM is rated a N/A out of 5.

GERM Tradability

175,708
$5.41M
140,807
$4.25M
0.45%
$0.13
0.18%
1.44% / -0.34%
None
--
50,000
2.82
0.05%
--
--
$31.66
N/A

GERM Sector/Industry Breakdown


GERM
Segment Benchmark
54.94%
100.00%
18.74%
--
16.46%
--
9.85%
--

GERM Top 10 Holdings[View All]

9.53%
5.61%
5.39%
5.14%
5.02%
5.00%
4.86%
4.83%
4.73%
3.96%
54.07%

GERM Countries


GERM
Segment Benchmark
91.13%
75.43%
6.28%
--
1.30%
0.38%
0.67%
0.20%
0.62%
1.61%
--
0.03%
--
1.24%
--
0.03%
--
5.04%
--
0.40%

GERM Regions


GERM
Segment Benchmark
91.13%
75.69%
6.90%
10.34%
1.97%
13.97%

GERM Economic Development


GERM
Segment Benchmark
93.72%
99.24%
6.28%
0.76%

GERM Performance Statistics

--
--
--
--
0.00%
Thomson Reuters Global Biotechnology & Medical Research

GERM Benchmark Comparison Holdings

56
220
8
5.57%

GERM Benchmark Comparison Summary


GERM
Segment Benchmark
56
220
$19.98B
$32.29B
-36.15
-77.28
5.79
6.36
0.38%
0.50%
Medium
Medium

GERM Benchmark Comparison Market Cap Size


GERM
Segment Benchmark
39.00%
59.39%
31.37%
26.57%
22.45%
12.27%
7.19%
1.77%